HCA Healthcare, Inc. (HCA)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $104.25B
Last updated: Nov 17, 2026 at 11:06 AM ET
HCA Healthcare, Inc. (HCA) Financials: Revenue, Profit and Cash Flow
HCA Healthcare reported revenue of $75.60B for the fiscal year ended Dec 31, 2025, up 7.1% from the year before. That year, net income was $7.78B with a net margin of 10.3%, operating cash flow was $12.64B and free cash flow was $7.69B. The quarter ended Sep 30, 2026 had revenue of $19.85B and net income of $1.85B.
Revenue and Margins
The operating margin was 16.0% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $41.49B, a compound annual rate of 6.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $75.60B | +7.1% | 41.5% | 16.0% | 10.3% |
| Dec 2024 | $70.60B | +8.7% | 40.6% | 15.0% | 9.4% |
| Dec 2023 | $64.97B | +7.9% | 54.6% | 14.8% | 9.4% |
| Dec 2022 | $60.23B | +2.5% | 84.4% | 17.2% | 11.3% |
| Dec 2021 | $58.75B | +14.0% | 54.4% | 19.2% | 13.1% |
| Dec 2020 | $51.53B | +0.4% | 53.7% | 14.1% | 8.5% |
| Dec 2019 | $51.34B | +10.0% | 83.5% | 14.1% | 8.1% |
| Dec 2018 | $46.68B | +7.0% | 37.6% | 15.2% | 9.4% |
| Dec 2017 | $43.61B | +5.1% | 83.2% | 13.9% | 6.3% |
| Dec 2016 | $41.49B | N/A | 54.5% | 15.6% | 8.3% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 16.8% from the year before. In the quarter ended Sep 2026, net income fell 2.6% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B |
| Cost of revenue | $44.23B | $41.92B | $29.49B | $9.37B | $26.78B | $23.87B | $8.48B | $29.15B | $7.32B | $18.90B |
| Gross profit | $31.37B | $28.68B | $35.48B | $50.86B | $31.97B | $27.66B | $42.85B | $17.53B | $36.30B | $22.59B |
| Operating income | $12.08B | $10.58B | $9.62B | $10.35B | $11.30B | $7.25B | $7.24B | $7.09B | $6.07B | $6.47B |
| Net income | $7.78B | $6.66B | $6.09B | $6.83B | $7.72B | $4.39B | $4.14B | $4.39B | $2.74B | $3.43B |
| EBITDA | $15.65B | $13.93B | $12.73B | $13.35B | $14.18B | $10.01B | $9.86B | $9.40B | $8.23B | $8.47B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.85B | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B | $17.49B | $17.49B | $17.34B | $17.30B |
| Gross profit | $11.27B | $11.94B | $10.83B | -$214.00M | $16.38B | $10.47B | $10.32B | -$2.77B | $9.63B | $14.86B | $6.96B | $4.93B |
| Operating income | $2.96B | $3.08B | $2.86B | $3.30B | $2.96B | $2.96B | $2.86B | $2.68B | $2.41B | $2.74B | $2.76B | $2.83B |
| Net income | $1.85B | $1.93B | $1.86B | $2.16B | $1.90B | $1.89B | $1.82B | $1.69B | $1.48B | $1.69B | $1.80B | $1.86B |
Balance Sheet
As of Dec 2025, total debt of $46.49B exceeded cash and equivalents by $45.45B. Shareholder equity was negative, at -$6.03B, as total liabilities of $63.49B exceeded total assets of $60.72B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B |
| Current assets | $15.78B | $16.41B | $14.93B | $13.64B | $13.54B | $12.33B | $11.20B | $10.21B | $9.98B | $9.09B |
| Cash and equivalents | $1.04B | $1.93B | $935.00M | $908.00M | $1.45B | $1.79B | $621.00M | $502.00M | $732.00M | $646.00M |
| Total liabilities | $63.49B | $58.96B | $55.15B | $52.51B | $49.25B | $44.60B | $45.62B | $42.13B | $41.59B | $39.39B |
| Short-term debt | $4.89B | $4.70B | $2.42B | $370.00M | $237.00M | $209.00M | $145.00M | $788.00M | $200.00M | $216.00M |
| Long-term debt | $41.60B | $38.33B | $37.17B | $37.71B | $34.34B | $30.80B | $33.58B | $32.03B | $32.86B | $31.16B |
| Shareholder equity | -$6.03B | -$2.50B | -$1.77B | -$2.77B | -$933.00M | $572.00M | -$2.81B | -$4.95B | -$6.81B | -$7.30B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $63.45B | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | $56.21B |
| Total liabilities | $68.05B | $66.46B | $64.43B | $63.49B | $61.91B | $60.77B | $60.24B | $58.96B | $58.67B | $56.04B | $55.69B | $55.15B |
| Cash and equivalents | $908.00M | $1.01B | $940.00M | $1.04B | $997.00M | $939.00M | $1.06B | $1.93B | $2.89B | $831.00M | $1.28B | $935.00M |
| Shareholder equity | -$8.08B | -$6.64B | -$6.30B | -$2.77B | -$5.33B | -$4.39B | -$3.52B | $555.00M | -$2.18B | -$1.60B | -$1.61B | $1.06B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 60.8% of operating cash flow. Dividends and share repurchases together came to 150.5% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $12.64B | $10.51B | $9.43B | $8.52B | $8.96B | $9.23B | $7.60B | $6.76B | $5.43B | $5.65B |
| Capital expenditures | $4.94B | $4.88B | $4.74B | $4.39B | $3.58B | $2.83B | $4.16B | $3.57B | $3.02B | $2.76B |
| Free cash flow | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B | $6.40B | $3.44B | $3.19B | $2.41B | $2.89B |
| Dividends paid | $1.51B | $1.40B | $1.30B | $1.68B | $1.37B | $779.00M | $1.09B | $928.00M | $448.00M | $434.00M |
| Share repurchases | $10.07B | $6.04B | $3.81B | $7.00B | $8.21B | $441.00M | $1.03B | $1.53B | $2.05B | $2.75B |
| Investing cash flow | -$4.99B | -$4.93B | -$5.32B | -$3.39B | -$2.64B | -$3.39B | -$5.72B | -$3.90B | -$4.28B | -$3.24B |
| Financing cash flow | -$8.55B | -$4.58B | -$4.09B | -$5.66B | -$6.66B | -$4.68B | -$1.77B | -$3.08B | -$1.06B | -$2.51B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.46B | $2.33B | $2.01B | $2.36B | $4.42B | $4.21B | $1.65B | $2.56B | $3.52B | $1.97B | $2.47B | $2.67B |
| Capital expenditures | $1.36B | $1.23B | $1.12B | $1.49B | $1.29B | $1.18B | $991.00M | $1.28B | $1.19B | $1.28B | $1.12B | $1.16B |
| Free cash flow | $3.10B | $1.10B | $895.00M | $870.00M | $3.13B | $3.03B | $660.00M | $1.27B | $2.32B | $690.00M | $1.35B | $1.51B |
Frequently Asked Questions About HCA
What is HCA Healthcare's annual revenue?
HCA Healthcare reported revenue of $75.60B for the fiscal year ended Dec 31, 2025.
How fast is HCA Healthcare's revenue growing?
Revenue was up 7.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 7.9%.
Is HCA Healthcare profitable?
Yes. HCA Healthcare reported net income of $7.78B for the fiscal year ended Dec 31, 2025, with a net margin of 10.3%.
How much free cash flow does HCA generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $12.64B minus capital expenditures of $4.94B produced free cash flow of $7.69B.
How much debt does HCA Healthcare have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $41.60B, short-term debt of $4.89B and cash and equivalents of $1.04B.
HCA pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors